NCT03431649View on ClinicalTrials.gov

Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

July 30, 2017

Study Completion Date

October 30, 2017

Conditions
Pediatric Pulmonary Hypertension
Interventions
DRUG

Beraprost Sodium

1 mcg /kgbw daily, divided in three dosages orally for 12 weeks

DRUG

Sildenafil Citrate

0.4 mg/kgbw each time, 4 times in a day orally for 12 weeks

Trial Locations (1)

Unknown

Dr. Soetomo General Hospital, Surabaya

All Listed Sponsors
lead

Dr. Soetomo General Hospital

OTHER_GOV

NCT03431649 - Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children | Biotech Hunter | Biotech Hunter